Avidity Biosciences
Research, development, and manufacturing of drug candidates which include antibody-sirna complexes. Learn more
Launch date
Employees
Market cap
$4.9b
Enterprise valuation
$3.6b (Public information from Sep 2024)
Share price
$45.65 RNA
San Diego California (HQ)
Authorizing premium user...